Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ian W. Ratcliffe | M | 63 | 2 years | |
Martin Stefanelli | M | 63 |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | 2 years |
Martyn Coombs | M | - | 4 years | |
David Jones | M | 66 | - | |
John R. Cullinane | M | - | - | |
Randal Charlton | M | - |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | - |
James F. Eliason | M | - |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | - |
George Azrak | M | - |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | - |
Christine Milne | F | - |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | - |
Christina DeHayes | F | - |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | - |
Mina Sooch | F | 56 | - | |
Dalia Cohen | M | 71 | - | |
Michael J. Null | M | 54 |
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 7 | 53.85% |
United Kingdom | 6 | 46.15% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Stchur
- Personal Network